Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,620 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06316583Recruiting
Dry needling for painful periods study
This trial tests whether dry needling (a type of acupuncture) can help relieve primary dysmenorrhea (painful periods without another cause). It compares the effects on specific acupoints to see which works best.
Beijing, Beijing MunicipalityAges 18–30 - NCT06316895Recruiting
Thermal ablation for small, low-risk thyroid cancer
This trial is studying a treatment called thermal ablation (using heat to destroy cancer cells) for people with small, low-risk papillary thyroid cancer. It aims to see how well it works and to predict outcomes.
BeijingAges 18–80 - NCT06318585Recruiting
Building a database for motor neuron disease research
This study collects information from people with ALS or other motor neuron diseases to better understand how these conditions vary. By joining a database, you help researchers find patterns that could improve care.
Milan, MIAges 18 years+ - NCT06320925Recruiting
SportsPro study after joint surgery
This study follows patients who had joint repair with specific Stryker devices to see how well the procedure works in daily life.
Phoenix, ArizonaAges 18 years+ - NCT06322238RecruitingPhase 2
Can a DNA test help prevent drug side effects in primary care?
This study tests whether a cheek-swab DNA test can help doctors choose safer medicines for you. If you are starting a new drug in primary care, you might join to help prevent side effects.
Rochester, MinnesotaAges 18 years+ - NCT06323369RecruitingPhase 2
Tislelizumab plus chemo before surgery vs surgery alone for head and neck cancer
This trial tests whether giving tislelizumab (an immunotherapy) with chemotherapy before surgery works better than surgery alone for people with head and neck cancer that has not spread to lymph nodes. It's for cancers that can be removed with surgery, and the goal is to see if the pre-surgery treatment improves outcomes.
Guangzhou, YuexiuAges 18–75 - NCT06324201Recruiting
Long-term safety of a new ablation system for paroxysmal AF
This study tests a new system (QDOT MICRO and VISITAG SURPOINT) used during a catheter ablation procedure to treat atrial fibrillation (AF). It aims to see how safe and effective it is over the long term for people whose AF comes and goes and hasn't been controlled by medication.
Birmingham, AlabamaAges 18 years+ - NCT06324682Recruiting
Comparing heart pacemaker types for better treatment
This trial looks at different ways to pace the heart (like left, right, or both sides) to see which works best for people who need a pacemaker. If you have a heart condition requiring a pacemaker, this study may help find the safest and most effective option for you.
Ferrara, FEAges 18 years+ - NCT06325046Recruiting
Adaptive radiation therapy for localized prostate cancer
This trial tests a type of radiation that adapts to your body's changes during treatment. It is for men with low- to intermediate-risk prostate cancer that hasn't spread.
Albert Lea, MinnesotaAges 18 years+ - NCT06326008RecruitingPhase 1
Donor immune cell therapy for leukemia that returned after treatment
This trial tests a two-step approach using donor immune cells to treat children with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to standard treatments. First, a donor's CD19-targeted cells are given to bridge to a stem cell transplant, followed by CD22-targeted cells to prevent relapse.
Beijing, Beijing MunicipalityAges 1–18 - NCT06325982Recruiting
Preventing rectal injury from radiation with a medicated enema
This trial tests whether a medicated enema can help prevent radiation damage to the rectum during pelvic radiotherapy. It may be a good option if you are starting radiation to the pelvis or rectum and are otherwise in good health.
Xiamen, FujianAges Any age - NCT07694843RecruitingPhase 1
Study of ammoxetine for people with mild to moderate liver problems
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
Suzhou, JiangsuAges 18–75 - NCT06033950RecruitingPhase 3
A study of finerenone for heart failure patients who can't take standard MRA drugs
This study tests whether finerenone, a new type of drug, can help people with heart failure who cannot take standard steroid-based MRAs (a kind of heart medication) because of side effects or other reasons. It aims to see if it improves symptoms and is safe for you.
Fairhope, AlabamaAges 18 years+ - NCT07655388Recruiting
Wound healing and dressing changes after hip replacement
This study compares different types of dressings and how often they should be changed after total hip replacement surgery. It aims to find the best way to help the surgical wound heal.
Novi SadAges 65–95 - NCT05199259Recruiting
Blood test study for people at risk for or with liver cancer
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
Escondido, CaliforniaAges 18 years+ - NCT03942328RecruitingPhase 1/Phase 2
Immune cell vaccine plus checkpoint treatment after liver radiation
This trial tests a combination of a personalized immune cell treatment (made from your own cells) and a pneumococcal vaccine along with an “immune checkpoint” drug after high-dose radiation for certain unresectable liver cancers. The goal is to help your immune system better attack the cancer and to see how safe and effective this approach is.
Rochester, MinnesotaAges 18 years+ - NCT06591117Recruiting
Study of a new eye implant for stubborn glaucoma
This study tests a new device to lower eye pressure in people with hard-to-control glaucoma. It is for those who have not had success with other treatments and have open-angle or traumatic glaucoma with high eye pressure.
Colonia Escalón, San SalvadoreAges 22–85 - NCT07696832Recruiting
Ivonescimab as first treatment for advanced lung cancer
This trial studies ivonescimab alone as a first treatment for people with advanced non-small cell lung cancer (NSCLC) that tests positive for PD-L1 and doesn't have certain gene changes. The goal is to see if it works and is safe in everyday medical practice.
Guangzhou, GuangdongAges 18 years+ - NCT07694648Recruiting
Watching for germs that cause breathing problems
This study tracks patients with breathing problems to see which germs are making them sick. Doctors will use tests and medical records to watch for different pathogens.
Beijing, Beijing MunicipalityAges Any age - NCT06008080Recruiting
Study following patients after Navitor valve implant
This study is checking how well the Navitor heart valve works in real-world patients. If you are scheduled to get this valve, you may be able to join.
AdelaideAges 18–100 - NCT07048314RecruitingPhase 1/Phase 2
Stem cells for erectile dysfunction after prostate surgery
This trial tests if stem cells can help restore erectile function in men who have had prostate cancer surgery (RALP). It is for men with localized, low-risk cancer and good sexual function before surgery.
Houston, TexasAges 40–70 - NCT07049003RecruitingPhase 1
Deep brain stimulation for severe tremor
This trial tests a new type of deep brain stimulation (DBS) for people with severe tremor from essential tremor, multiple sclerosis, or cerebellar conditions who haven't improved with standard treatments. It targets a different brain area to see if it can reduce shaking and improve daily activities.
Cleveland, OhioAges 21 years+ - NCT07526766Recruiting
Exercise Program for Heart Artery Dissection and Fibromuscular Dysplasia
This study tests whether a supervised exercise program is safe and helpful for people who have had a spontaneous tear in a heart artery (SCAD) or fibromuscular dysplasia (a condition affecting blood vessel walls). The goal is to see if exercise can improve heart health after recovery from these conditions.
Jacksonville, FloridaAges 21–65 - NCT07089576Recruiting
Study of the Arcevo LSA device for aortic arch repair
This trial tests a new device called Arcevo LSA to treat certain types of aortic arch problems, like dissections (tears) or aneurysms (bulges). It is for people who need open surgery, and the device helps fix the left subclavian artery area.
Birmingham, AlabamaAges 18–80
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,620 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.